Remove 2019 Remove Clinical Trials Remove Conditions
article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

article thumbnail

Ohio Gives Another Shot at Expanding Qualifying Conditions

Veriheal

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523. Strict Guidelines Must be Met Before Conditions Will Be Considered.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. References Staff, T.

article thumbnail

Cannabis as a cancer cure: what is the research and where is it going?

The Cannigma

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. The answer: Maybe!

article thumbnail

A Moral COMPASS to Treat Mental Health Disorders Using the Magic of Psilocybin

NewsMunchies

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. In 2019, Denver became the first city in the U.S.

article thumbnail

Medical Marijuana For Anxiety And Mood Disorder Treatment

LifeCannMD

Various clinical trials are investigating the effectiveness of cannabis and its components in treating PTSD symptoms. For example, a 2019 study found that CBD significantly reduced anxiety in teenagers with social anxiety disorder. Some studies have shown promising results, particularly with CBD.

article thumbnail

South African Research Team Says Cannabis is ‘Very Promising’ as an Opioid Replacement

Veriheal

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. According to the announcement, Biodata—a subsidiary of Labat Africa—“is the brainchild of Dr. Quite frankly, the clinical trials couldn’t have come at a better time. I don’t think it works for severe pain.